INS and type 1 diabetes mellitus: Type 1 diabetes mellitus (T1DM) is a multifactorial autoimmune disease characterized by destruction of pancreatic beta cells.1 Patients with T1DM have to use exogenous insulin replacement from diagnosis and face the risks of developing micro- and macro-vascular complications, potentially leading to a poor quality of life and premature mortality.2,3